The Board of Directors of the Company in its meeting held on Tuesday, 26th May, 2026 has considered and approved the following business:- 1. Audited Standalone and Consolidated Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
TCM Limited reported a significant deterioration in financial performance for FY2026. Standalone revenue declined to ₹1,723.48 Lakhs from ₹2,472.74 Lakhs (down 30%), while consolidated revenue fell to ₹1,973.84 Lakhs from ₹2,600.61 Lakhs. The company swung from a standalone profit of ₹311.52 Lakhs in FY25 to a loss of ₹366.32 Lakhs, and from a consolidated profit of ₹136.53 Lakhs to a loss of ₹602.47 Lakhs. Finance costs more than tripled to ₹192 Lakhs from ₹59 Lakhs due to increased borrowings. The auditors from SGM & Associates LLP issued unmodified opinions on both standalone and consolidated financial statements. The company appointed Jomy Saimon and Associates as internal auditors for FY2026-27.
The sharp revenue decline and transition to significant losses, combined with tripled finance costs and negative operating cash flows of ₹449.70 Lakhs (standalone), signal substantial financial stress. The clean audit opinion provides some comfort, but shareholders should monitor the company's ability to service its increased debt burden of ₹2,216.46 Lakhs in current borrowings.